CI
CVS icon

Conning Inc’s CVS Health CVS Stock Holding History

Conning Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Sell
4,771
-2,020
-30% -$156K 0.01% 245
2025
Q4 		$539K Sell
6,791
-1,138
-14% -$89.7K 0.02% 222
2025
Q3 		$598K Hold
7,929
– – 0.02% 215
2025
Q2 		$547K Sell
7,929
-325
-4% -$21.3K 0.02% 218
2025
Q1 		$559K Hold
8,254
– – 0.02% 216
2024
Q4 		$371K Sell
8,254
-113
-1% -$6.34K 0.01% 266
2024
Q3 		$526K Sell
8,367
-8,350
-50% -$487K 0.02% 228
2024
Q2 		$987K Sell
16,717
-495,932
-97% -$31M 0.04% 172
2024
Q1 		$40.8M Buy
512,649
+37,387
+8% +$2.86M 1.34% 13
2023
Q4 		$37.4M Sell
475,262
-59,575
-11% -$4.24M 1.3% 12
2023
Q3 		$37.3M Buy
534,837
+30,004
+6% +$2.13M 1.36% 6
2023
Q2 		$34.8M Buy
504,833
+75,717
+18% +$5.39M 1.17% 46
2023
Q1 		$31.8M Buy
429,116
+68,626
+19% +$5.75M 1.06% 51
2022
Q4 		$33.5M Buy
360,490
+17,092
+5% +$1.65M 1.09% 50
2022
Q3 		$32.7M Buy
343,398
+327,180
+2,017% +$32.4M 1.16% 31
2022
Q2 		$1.5M Sell
16,218
-237
-1% -$23.1K 0.05% 170
2022
Q1 		$1.67M Buy
16,455
+47
+0.3% +$4.94K 0.05% 170
2021
Q4 		$1.69M Sell
16,408
-216
-1% -$20K 0.05% 161
2021
Q3 		$1.41M Sell
16,624
-730
-4% -$61.1K 0.04% 171
2021
Q2 		$1.45M Sell
17,354
-3,512
-17% -$288K 0.04% 167
2021
Q1 		$1.57M Sell
20,866
-1,550
-7% -$113K 0.05% 161
2020
Q4 		$1.53M Sell
22,416
-723
-3% -$47K 0.05% 159
2020
Q3 		$1.35M Buy
23,139
+280
+1% +$17.4K 0.05% 163
2020
Q2 		$1.49M Buy
22,859
+570
+3% +$35.9K 0.06% 157
2020
Q1 		$1.32M Sell
22,289
-2,474
-10% -$165K 0.06% 155
2019
Q4 		$1.84M Buy
24,763
+3,585
+17% +$252K 0.06% 159
2019
Q3 		$1.34M Sell
21,178
-839
-4% -$49.7K 0.05% 190
2019
Q2 		$1.2M Sell
22,017
-22,954
-51% -$1.24M 0.04% 200
2019
Q1 		$2.42M Sell
44,971
-3,764
-8% -$232K 0.08% 165
2018
Q4 		$3.19M Buy
48,735
+3,578
+8% +$267K 0.11% 124
2018
Q3 		$3.56M Sell
45,157
-21,857
-33% -$1.56M 0.11% 123
2018
Q2 		$4.31M Sell
67,014
-460,441
-87% -$30.3M 0.13% 116
2018
Q1 		$32.8M Buy
527,455
+118,254
+29% +$8.48M 1.06% 47
2017
Q4 		$29.7M Buy
409,201
+26,510
+7% +$1.93M 0.98% 43
2017
Q3 		$31.1M Buy
382,691
+332,252
+659% +$26.3M 1.06% 36
2017
Q2 		$4.06M Buy
50,439
+1,253
+3% +$98.9K 0.15% 117
2017
Q1 		$3.86M Sell
49,186
-2,689
-5% -$215K 0.14% 117
2016
Q4 		$4.09M Buy
51,875
+1,390
+3% +$112K 0.16% 112
2016
Q3 		$4.49M Buy
50,485
+110
+0.2% +$10.4K 0.18% 100
2016
Q2 		$4.82M Buy
50,375
+120
+0.2% +$12K 0.2% 93
2016
Q1 		$5.21M Buy
50,255
+220
+0.4% +$21.4K 0.22% 82
2015
Q4 		$4.89M Sell
50,035
-1,550
-3% -$152K 0.21% 91
2015
Q3 		$4.98M Sell
51,585
-3,100
-6% -$326K 0.22% 85
2015
Q2 		$5.74M Sell
54,685
-440
-0.8% -$45K 0.24% 84
2015
Q1 		$5.69M Sell
55,125
-530
-1% -$53.6K 0.24% 76
2014
Q4 		$5.36M Sell
55,655
-1,170
-2% -$103K 0.26% 74
2014
Q3 		$4.52M Sell
56,825
-1,730
-3% -$136K 0.24% 83
2014
Q2 		$4.41M Sell
58,555
-4,157
-7% -$314K 0.23% 84
2014
Q1 		$4.7M Buy
62,712
+1,480
+2% +$105K 0.28% 78
2013
Q4 		$4.38M Sell
61,232
-446
-0.7% -$28.7K 0.27% 77
2013
Q3 		$3.5M Buy
61,678
+7,216
+13% +$430K 0.27% 83
2013
Q2 		$3.11M Buy
+54,462
New +$3.16M 0.26% 86

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Conning Inc's CVS Position: Q1 2026 in Review

Conning Inc reduced its CVS Health (CVS) stake by 30% in Q1 2026, selling an estimated $156K and leaving 4,771 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #245.

Conning Inc first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $40.8M in Q1 2024. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Conning Inc held 4,771 shares of CVS Health worth $343K as of Q1 2026.
  • Conning Inc sold 2,020 CVS Health shares in Q1 2026, an estimated $156K.
  • CVS Health made up 0.01% of Conning Inc's portfolio in Q1 2026, its #245 holding.
  • Conning Inc first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's CVS Health position peaked at $40.8M in Q1 2024.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.